Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 6/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | FAP | Q12884 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL137918 | 0.87 | DPP4 (0.34) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL138094 | 0.84 | DPP4 (0.38) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL11858950 | 0.84 | SLC7A5 (0.36) | DPP4DPP8DPP9DPP7MMP3 | |
| SCHEMBL1537227 | 0.84 | SLC7A5 (0.36) | DPP4DPP8DPP9DPP7MMP3 | |
| SCHEMBL756555 | 0.84 | SLC7A5 (0.36) | DPP4DPP8DPP9DPP7MMP3 | |
| SCHEMBL6894684 | 0.79 | DPP4 (0.38) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL8941804 | 0.74 | DPP4 (0.40) | DPP4DPP8DPP9DPP7RAB9A | |
| SCHEMBL4354920 | 0.73 | RAB9A (0.33) | RAB9A | |
| SCHEMBL11036662 | 0.71 | DPP4 (0.47) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL3489282 | 0.70 | NOS2 (0.35) | DPP4DPP8DPP9DPP7FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8673854-B2 | Prophylactic agent for heart failure | CALPIS CO., LTD. (JP) | 2014-03-18 | — | — | US | disclosed |
| EP-2138184-B1 | TRIPEPTIDES FOR USE IN PREVENTING KIDNEY GLOMERULAR DISEASE | CALPIS CO LTD (JP) | 2013-09-18 | — | — | EP | disclosed |
| EP-2130546-B1 | TRIPEPTIDES FOR USE IN TREATING HEART WALL THICKENING | CALPIS CO LTD (JP) | 2013-02-27 | — | — | EP | disclosed |
| US-20120077735-A1 | PROPHYLACTIC AGENT FOR RENAL FAILURE | HIROTA TATSUHIKO (JP) | 2012-03-29 | — | — | US | disclosed |
| US-20120058947-A1 | PROPHYLACTIC AGENT FOR HEART FAILURE | ASAHI GROUP FOODS, LTD. (JP) | 2012-03-08 | — | — | US | disclosed |
| US-20100022748-A1 | PROPHYLACTIC AGENT FOR RENAL FAILURE | CALPIS CO., LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
| US-20100022747-A1 | PROPHYLACTIC AGENT FOR HEART FAILURE | CALPIS CO., LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
| EP-2138184-A1 | PROPHYLACTIC AGENT FOR RENAL FAILURE | Calpis Co., Ltd. (JP) | 2009-12-30 | — | — | EP | disclosed |
| EP-2130546-A1 | PROPHYLACTIC AGENT FOR HEART FAILURE | Calpis Co., Ltd. (JP) | 2009-12-09 | — | — | EP | disclosed |